Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
DEA finalizes specific listing for hexahydrocannabinol (HHC) as a Schedule I controlled substance, imposing immediate regulatory controls on its production, distribution, and possession.
Aforeworn detected this change in the Cannabis & Hemp Operators space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Critical. Hemp-derived THC brands, processors/manufacturers, cultivators, dispensaries should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; no grace period provided.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cannabis & Hemp Operators continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
HHC is now explicitly listed as a Schedule I substance with a DEA drug code, removing any ambiguity about its legal status under federal law.
Who it affects
Hemp-derived THC brands, processors/manufacturers, cultivators, dispensaries
What you must do
Immediately cease all production, sale, and distribution of HHC products; destroy existing inventory in compliance with DEA regulations; update compliance protocols to exclude HHC.
Deadline
Immediate; no grace period provided.
Never miss a change like this again
Aforeworn watches Cannabis & Hemp Operators around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cannabis & Hemp Operators
- Oregon Liquor and Cannabis Commission : Marijuana and Hemp (Cannabis) : Marijuana and Hemp (Cannabis) : State of Oregon
- Rulemaking - Department of Cannabis Control
- Federal Acquisition Regulation: List of Domestically Nonavailable Articles
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration's Adverse Event and Product Experience Reporting Program
- Exempt Chemical Preparations Under the Controlled Substances Act